000 | 01495 a2200385 4500 | ||
---|---|---|---|
005 | 20250514235408.0 | ||
264 | 0 | _c20051213 | |
008 | 200512s 0 0 eng d | ||
022 | _a0885-3185 | ||
024 | 7 |
_a10.1002/mds.20545 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLang, Anthony E | |
245 | 0 | 0 |
_aTreatment of progressive supranuclear palsy and corticobasal degeneration. _h[electronic resource] |
260 |
_bMovement disorders : official journal of the Movement Disorder Society _cAug 2005 |
||
300 |
_aS83-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAmantadine _xtherapeutic use |
650 | 0 | 4 |
_aCerebral Cortex _xpathology |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aCorpus Striatum _xpathology |
650 | 0 | 4 | _aDonepezil |
650 | 0 | 4 |
_aDopamine Agents _xtherapeutic use |
650 | 0 | 4 |
_aDopamine Agonists _xtherapeutic use |
650 | 0 | 4 |
_aDystonia _xdrug therapy |
650 | 0 | 4 |
_aGlobus Pallidus _xpathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndans _xtherapeutic use |
650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
650 | 0 | 4 |
_aNerve Degeneration _xdrug therapy |
650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
650 | 0 | 4 |
_aSubstantia Nigra _xpathology |
650 | 0 | 4 |
_aSupranuclear Palsy, Progressive _xdrug therapy |
773 | 0 |
_tMovement disorders : official journal of the Movement Disorder Society _gvol. 20 Suppl 12 _gp. S83-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/mds.20545 _zAvailable from publisher's website |
999 |
_c15730138 _d15730138 |